Cardiac Medications -Management of Complex Cardiovascular Disorders by Karen M. Marzlin,
Salepage link: At HERE. Archive:
- Karen M. Marzlin
- Full Day
- Audio and Video
- Mar 11, 2016
Join Karen M. Marzlin, DNP, RN, CCNS, CCRN-CMC, CHFN, for an insightful and practical day focused on the common types of cardiac disorders that professionals like you see in your practice, and the medications currently used to treat them.
Drawing from three decades of experience treating cardiology patients, Karen will provide you with cutting-edge information regarding the selection of particular cardiac medications, the desired outcomes, potential side effects and drug interactions. Leave with a clear understanding of the physiological basis for cardiovascular drug therapy and drugs used to manipulate hemodynamic parameters, alter the cardiac electrical system, interrupt the clotting process, and to treat a variety of cardiovascular disease states.
Don’t miss this opportunity to keep pace with the ever-changing field of cardiac care, and through the information gained in this seminar, reduce the risk of potential adverse consequences for your patients. You will leave with a holistic perspective of cardiovascular pharmacology and its role in providing your patient with better outcomes and quality of life.
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
|Webcast Manual (7.56 MB)||61 Pages||Available after Purchase|
Hemodynamics and Shock
- Physiological determinants of myocardial performance
- Shock: Dopamine versus Norepinephrine
- Nuances of decompensated heart failure
Risk Factor Optimization
- Statin therapy in primary and secondary prevention
- Other Antilipid agents: when to use what?
- Outcome trials for lipid lowering agents
- AIM High
- Drug choices in hypertension
- Resistant hypertension
- Antiarrhythmic pharmacology for rate control
- Antiarrhythmic pharmacology for rhythm control
- Clinical implications of potassium channel blockers
- Special considerations for Dronedarone and Amiodarone
- Anticoagulant medication options
Therapeutic Advances for Acute Coronary Syndrome
- Epleranone post-STEMI
- ASA and CABG
- Contrast nephropathy
- Optimal loop diuretic / dose and route of administration
- OPTIME Trial
- RAAS drugs
- Evidence-based beta blockers
- Drugs not to give for systolic dysfunction
Pulling it All Together: A Patient-Centered Approach to Pharmacology and Prescribing
Karen M. Marzlin, DNP, RN, CCNS, CCRN-CMC Related seminars and products: 5
Acute Care Clinical Nurse Specialist/Co-Owner
Karen M. Marzlin, DNP, RN, CCNS, CCRN-CMC, CHFN, is an acute care Clinical Nurse Specialist practicing with medical cardiology patients in a 56-bed variable staffing CCU. Karen has been a nurse for over 26 years and has spent her entire career working with the cardiac patient. Karen also dedicated 10 years of her career to management and cardiovascular program administration. She has a passion for creating excellence at the bedside that is evident in her daily practice.
Karen, in addition to maintaining a part-time clinical practice, is a co-owner of Key Choice, a training and consulting business. She travels nationally and provides continuing education on a wide variety of cardiovascular and critical care topics as well as leadership/management consulting. Her presentations are enthusiastically delivered and offer practical tips that help everyone achieve excellence at the bedside. Linking knowledge to practice is the goal of every education program.
Karen collaborated on Cardiovascular Nursing Practice: A Comprehensive Nursing Resource Manual published by CNEA in 2007.
Financial: Karen Marzlin receives a speaking honorarium from PESI, Inc.
Nonfinancial: Karen Marzlin has no relevant nonfinancial relationship to disclose.
There are no reviews yet.